Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
PaperCitations, authors & open-access status
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 921 citations, 2017 year and closed oa status.
921
Citations
2017
Year
closed
OA Status